The future of immunotherapy at the Optimizing Immunotherapy Congress

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

​The benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of thi...

Read more

We could hit a new milestone in the treatment of infertility

by GENESIS Biomed

Agnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as it increases the chances of embryo implantation a 65%. Arba...

Read more

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked & Available in Europe

by Promega Biotech Ibérica

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Read more

Research teams from the IRBLleida and the UdL confirm the validity and reliability of different qualitative measures to assess the sleep of adults with fibromyalgia

by IRB Lleida. Institut de Recerca Biomèdica

The review of the duration and depth of sleep or difficulty falling asleep allows us to offer comprehensive and personalized treatment to patients

Read more

An international research identifies a biomarker predicting prognosis for immunotherapy-treated patients with advanced cancer

by CIMA - Centro de Investigación Médica Aplicada

Researchers from Cima and the Clínica Universidad de Navarra show that high IL-8 levels are linked to worse patient response to the treatment

Read more

Advances and new horizons in the diagnosis and treatment of colorectal cancer

by Vall d’Hebron

To ring in this year’s colorectal cancer awareness month this coming March, we have organized a special workshop open to the public taking place on Thursday 27 February, from 18:00h-20:00h, C/Rossel...

Read more

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

by 3P Biopharmaceuticals

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, the UK ba...

Read more

Bioinformaticians, physicists and mathematicians join oncologists to uncover the heterogeneity of cancer with Big Data and personalise its treatment

by CNIO - Centro Nacional de Investigaciones Oncológicas

From 23 to 25 September, experts from around the world discuss at the international Congress CNIO-“la Caixa” Frontiers Meeting how the analysis of the currently available vast amounts of data on e...

Read more

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy based on animal models

by Clínica Universidad de Navarra

A collaborative experimental study, published in Nature and led by researchers at the University of Navarra, suggests TNF blockade may dissociate efficacy and toxicity in the use of combined immunothe...

Read more

Rare Disease Day: a new EU platform to support better diagnosis and treatment

by European Commission - Joint Research Centre

Today, marking Rare Disease Day, the European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Important focus on sperm of indigenous d...


All domestic animals such as cattle, goats, horses, sheep, dogs and ch...

Photos Stream